Prions: misfolded proteins and brain disease - Biology bibliographies - in Harvard style

In-text: (Acevedo-Morantes and Wille, 2014)

Your Bibliography: Acevedo-Morantes, C. and Wille, H., 2014. The Structure of Human Prions: From Biology to Structural Models — Considerations and Pitfalls. Viruses, 6(10), pp.3875-3892.

In-text: (Acquatella-Tran Van Ba, Imberdis and Perrier, 2013)

Your Bibliography: Acquatella-Tran Van Ba, I., Imberdis, T. and Perrier, V., 2013. From Prion Diseases to Prion-Like Propagation Mechanisms of Neurodegenerative Diseases. International Journal of Cell Biology, 2013, pp.1-8.

In-text: (Alonso, Corbo and Beharry, 2013)

Your Bibliography: Alonso, A., Corbo, C. and Beharry, C., 2013. Abnormal hyperphosphorylation of tau and molecular mechanism of neurofibrillary degeneration. Alzheimer's & Dementia, 9(4), pp.P673-P674.

In-text: (Anfinsen, 1972)

Your Bibliography: Anfinsen, C., 1972. The Formation and Stabilisation of Protein Structure. Biochemical Journal, 128(4), pp.737-749.

In-text: (Apetri, Maki, Roder and Surewicz, 2006)

Your Bibliography: Apetri, A., Maki, K., Roder, H. and Surewicz, W., 2006. Early Intermediate in Human Prion Protein Folding As Evidenced by Ultrarapid Mixing Experiments. J. Am. Chem. Soc., 128(35), pp.11673-11678.

In-text: (Apetri, Surewicz and Surewicz, 2004)

Your Bibliography: Apetri, A., Surewicz, K. and Surewicz, W., 2004. The Effect of Disease-associated Mutations on the Folding Pathway of Human Prion Protein. Journal of Biological Chemistry, 279(17), pp.18008-18014.

In-text: (Araujo, 2013)

Your Bibliography: Araujo, A., 2013. Prionic diseases. Arquivos de Neuro-Psiquiatria, 71(9B), pp.731-737.

In-text: (Arias and Cuervo, 2011)

Your Bibliography: Arias, E. and Cuervo, A., 2011. Chaperone-mediated autophagy in protein quality control. Current Opinion in Cell Biology, 23(2), pp.184-189.

In-text: (Aulić, Bolognesi and Legname, 2013)

Your Bibliography: Aulić, S., Bolognesi, M. and Legname, G., 2013. Small-Molecule Theranostic Probes: A Promising Future in Neurodegenerative Diseases. International Journal of Cell Biology, 2013, pp.1-19.

In-text: (Baig et al., 2010)

Your Bibliography: Baig, S., Joseph, S., Tayler, H., Abraham, R., Owen, M., Williams, J., Kehoe, P. and Love, S., 2010. Distribution and Expression of Picalm in Alzheimer Disease. Journal of Neuropathology and Experimental Neurology, 69(10), pp.1071-1077.

In-text: (Ballard et al., 2011)

Your Bibliography: Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D. and Jones, E., 2011. Alzheimer's disease. The Lancet, 377(9770), pp.1019-1031.

In-text: (Barducci, Chelli, Procacci and Schettino, 2005)

Your Bibliography: Barducci, A., Chelli, R., Procacci, P. and Schettino, V., 2005. Misfolding Pathways of the Prion Protein Probed by Molecular Dynamics Simulations. Biophysical Journal, 88(2), pp.1334-1343.

In-text: (Baskakov et al., 2002)

Your Bibliography: Baskakov, I., Legname, G., Baldwin, M., Prusiner, S. and Cohen, F., 2002. Pathway Complexity of Prion Protein Assembly into Amyloid. Journal of Biological Chemistry, 277(24), pp.21140-21148.

In-text: (Berger et al., 2007)

Your Bibliography: Berger, Z., Roder, H., Hanna, A., Carlson, A., Rangachari, V., Yue, M., Wszolek, Z., Ashe, K., Knight, J., Dickson, D., Andorfer, C., Rosenberry, T., Lewis, J., Hutton, M. and Janus, C., 2007. Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy. Journal of Neuroscience, 27(14), pp.3650-3662.

In-text: (Beringue et al., 2012)

Your Bibliography: Beringue, V., Herzog, L., Jaumain, E., Reine, F., Sibille, P., Le Dur, A., Vilotte, J. and Laude, H., 2012. Facilitated Cross-Species Transmission of Prions in Extraneural Tissue. Science, 335(6067), pp.472-475.

In-text: (Blurton-Jones and LaFerla, 2006)

Your Bibliography: Blurton-Jones, M. and LaFerla, F., 2006. Pathways by Which Aβ Facilitates Tau Pathology. Current Alzheimers Research, 3(5), pp.437-448.

In-text: (Born, 2015)

Your Bibliography: Born, H., 2015. Seizures in Alzheimer’s disease. Neuroscience, 286, pp.251-263.

In-text: (Braak and Del Tredici, 2010)

Your Bibliography: Braak, H. and Del Tredici, K., 2010. The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathologica, 121(2), pp.171-181.

In-text: (Brown, Gajdusek, Gibbs and Asher, 1985)

Your Bibliography: Brown, P., Gajdusek, D., Gibbs, C. and Asher, D., 1985. Potential Epidemic of Creutzfeldt–Jakob Disease from Human Growth Hormone Therapy. New England Journal of Medicine, 313(12), pp.728-731.

In-text: (Brown et al., 2000)

Your Bibliography: Brown, P., Preece, M., Brandel, J., Sato, T., McShane, L., Zerr, I., Fletcher, A., Will, R., Pocchiari, M., Cashman, N., d'Aignaux, J., Cervenakova, L., Fradkin, J., Schonberger, L. and Collins, S., 2000. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology, 55(8), pp.1075-1081.

In-text: (Calzolai, 2003)

Your Bibliography: Calzolai, L., 2003. Influence of pH on NMR Structure and Stability of the Human Prion Protein Globular Domain. Journal of Biological Chemistry, 278(37), pp.35592-35596.

In-text: (Cardinale et al., 2005)

Your Bibliography: Cardinale, A., Filesi, I., Vetrugno, V., Pocchiari, M., Sy, M. and Biocca, S., 2005. Trapping Prion Protein in the Endoplasmic Reticulum Impairs PrPC Maturation and Prevents PrPSc Accumulation. Journal of Biological Chemistry, 280(1), pp.685-694.

In-text: (Caughey et al., 1991)

Your Bibliography: Caughey, B., Dong, A., Bhat, K., Ernst, D., Hayes, S. and Caughey, W., 1991. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry, 30(31), pp.7672-7680.

In-text: (Caughey, Ernst and Race, 1993)

Your Bibliography: Caughey, B., Ernst, D. and Race, R., 1993. Congo Red Inhibition of Scrapie Agent Replication. Journal of Virology, 67(10), pp.6270-6272.

In-text: (Cavalli et al., 2007)

Your Bibliography: Cavalli, A., Bolognesi, M., Capsoni, S., Andrisano, V., Bartolini, M., Margotti, E., Cattaneo, A., Recanatini, M. and Melchiorre, C., 2007. A Small Molecule Targeting the Multifactorial Nature of Alzheimer's Disease. Angewandte Chemie, 46(20), pp.3763-3766.

In-text: (Cervenakova et al., 1998)

Your Bibliography: Cervenakova, L., Goldfarb, L., Garruto, R., Lee, H., Gajdusek, D. and Brown, P., 1998. Phenotype-genotype studies in kuru: Implications for new variant Creutzfeldt-Jakob disease. Proceedings of the National Academy of Sciences, 95(22), pp.13239-13241.

In-text: (Cheng and Daggett, 2014)

Your Bibliography: Cheng, C. and Daggett, V., 2014. Molecular Dynamics Simulations Capture the Misfolding of the Bovine Prion Protein at Acidic pH. Biomolecules, 4(1), pp.181-201.

In-text: (Ciechanover and Kwon, 2015)

Your Bibliography: Ciechanover, A. and Kwon, Y., 2015. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med, 47(3), p.e147.

In-text: (Cohen et al., 2011)

Your Bibliography: Cohen, O., Prohovnik, I., Korczyn, A., Ephraty, L., Nitsan, Z., Tsabari, R., Appel, S., Rosenmann, H., Kahana, E. and Chapman, J., 2011. The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression. Acta Neurologica Scandinavica, 124(6), pp.368-374.

In-text: (Collinge et al., 2008)

Your Bibliography: Collinge, J., Whitfield, J., McKintosh, E., Frosh, A., Mead, S., Hill, A., Brandner, S., Thomas, D. and Alpers, M., 2008. A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philosophical Transactions of the Royal Society B: Biological Sciences, 363(1510), pp.3725-3739.

In-text: (Come, Fraser and Lansbury, 1993)

Your Bibliography: Come, J., Fraser, P. and Lansbury, P., 1993. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proceedings of the National Academy of Sciences, 90(13), pp.5959-5963.

In-text: (Corder et al., 1993)

Your Bibliography: Corder, E., Saunders, A., Strittmatter, W., Schmechel, D., Gaskell, P., Small, G., Roses, A., Haines, J. and Pericak-Vance, M., 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261(5123), pp.921-923.

In-text: (Cruchaga et al., 2012)

Your Bibliography: Cruchaga, C., Chakraverty, S., Mayo, K., Vallania, F., Mitra, R., Faber, K., Williamson, J., Bird, T., Diaz-Arrastia, R., Foroud, T., Boeve, B., Graff-Radford, N., St. Jean, P., Lawson, M., Ehm, M., Mayeux, R. and Goate, A., 2012. Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families. PLoS ONE, 7(2), p.e31039.

In-text: (DaSilva, Shaw and McLaurin, 2010)

Your Bibliography: DaSilva, K., Shaw, J. and McLaurin, J., 2010. Amyloid-β fibrillogenesis: Structural insight and therapeutic intervention. Experimental Neurology, 223(2), pp.311-321.

In-text: (DeMarco and Daggett, 2004)

Your Bibliography: DeMarco, M. and Daggett, V., 2004. From conversion to aggregation: Protofibril formation of the prion protein. Proceedings of the National Academy of Sciences, 101(8), pp.2293-2298.

In-text: (Dill and MacCallum, 2012)

Your Bibliography: Dill, K. and MacCallum, J., 2012. The Protein-Folding Problem, 50 Years On. Science, 338(6110), pp.1042-1046.

In-text: (Dudhatra et al., 2013)

Your Bibliography: Dudhatra, G., KumarAvinash, K., Modi, C., Awale, M., Patel, H. and Mody, S., 2013. Transmissible Spongiform Encephalopathies Affecting Humans. ISRN Infectious Diseases, 2013, pp.1-11.

In-text: (Duffy et al., 1974)

Your Bibliography: Duffy, P., Wolf, J., Collins, G., DeVoe, A., Streeten, B. and Cowen, D., 1974. Possible Person-to-Person Transmission of Creutzfeldt-Jakob Disease. New England Journal of Medicine, 290(12), pp.692-693.

In-text: (Fernández-Borges et al., 2013)

Your Bibliography: Fernández-Borges, N., Eraña, H., Elezgarai, S., Harrathi, C., Gayosso, M. and Castilla, J., 2013. Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism. International Journal of Cell Biology, 2013, pp.1-9.

In-text: (Ferreira, Lu, Orecchio and Kosik, 1997)

Your Bibliography: Ferreira, A., Lu, Q., Orecchio, L. and Kosik, K., 1997. Selective Phosphorylation of Adult Tau Isoforms in Mature Hippocampal Neurons Exposed to Fibrillar Aβ. Molecular and Cellular Neuroscience, 9(3), pp.220-234.

In-text: (Fujita et al., 2011)

Your Bibliography: Fujita, K., Yamaguchi, Y., Mori, T., Muramatsu, N., Miyamoto, T., Yano, M., Miyata, H., Ootsuyama, A., Sawada, M., Matsuda, H., Kaji, R. and Sakaguchi, S., 2011. Effects of a Brain-Engraftable Microglial Cell Line Expressing Anti-Prion scFv Antibodies on Survival Times of Mice Infected with Scrapie Prions. Cell Mol Neurobiol, 31(7), pp.999-1008.

In-text: (Garske and Ghani, 2010)

Your Bibliography: Garske, T. and Ghani, A., 2010. Uncertainty in the Tail of the Variant Creutzfeldt-Jakob Disease Epidemic in the UK. PLoS ONE, 5(12), p.e15626.

In-text: (Gerrish et al., 2012)

Your Bibliography: Gerrish, A., Russo, G., Richards, A., Moskvina, V., Ivanov, D., Harold, D., Sims, R., Abraham, R., Hollingworth, P., Chapman, J., Hamshere, M., Pahwa, J., Dowzell, K., Williams, A., Jones, N., Thomas, C., Stretton, A. and Morgan, A., 2012. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. Journal of Alzheimer's disease, 28(2), pp.377-387.

In-text: (Gill et al., 2013)

Your Bibliography: Gill, O., Spencer, Y., Richard-Loendt, A., Kelly, C., Dabaghian, R., Boyes, L., Linehan, J., Simmons, M., Webb, P., Bellerby, P., Andrews, N., Hilton, D., Ironside, J., Beck, J., Poulter, M., Mead, S. and Brandner, S., 2013. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ, 347(oct15 5), pp.f5675-f5675.

In-text: (Gotz, Chen, Van and Nitsch, 2001)

Your Bibliography: Gotz, J., Chen, F., Van, D. and Nitsch, R., 2001. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Abeta 42 Fibrils. Science, 293(5534), pp.1491-1495.

In-text: (Gregersen, Bross, Vang and Christensen, 2006)

Your Bibliography: Gregersen, N., Bross, P., Vang, S. and Christensen, J., 2006. Protein Misfolding and Human Disease. Annual Review of Genomics and Human Genetics, 7(1), pp.103-124.

In-text: (Guerreiro, Gustafson and Hardy, 2012)

Your Bibliography: Guerreiro, R., Gustafson, D. and Hardy, J., 2012. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiology of Aging, 33(3), pp.437-456.

In-text: (Guo et al., 2012)

Your Bibliography: Guo, J., Ren, H., Ning, L., Liu, H. and Yao, X., 2012. Exploring structural and thermodynamic stabilities of human prion protein pathogenic mutants D202N, E211Q and Q217R. Journal of Structural Biology, 178(3), pp.225-232.

In-text: (Head, 2013)

Your Bibliography: Head, M., 2013. Human prion diseases: Molecular, cellular and population biology. Neuropathology, 33(3), pp.221-236.

In-text: (Huang et al., 1999)

Your Bibliography: Huang, X., Atwood, C., Hartshorn, M., Multhaup, G., Goldstein, L., Scarpa, R., Cuajungco, M., Gray, D., Lim, J., Moir, R., Tanzi, R. and Bush, A., 1999. The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction. Biochemistry, 38(24), pp.7609-7616.

In-text: (Jackson, 2014)

Your Bibliography: Jackson, W., 2014. Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein. Disease Models & Mechanisms, 7(1), pp.21-29.

In-text: (Jetha et al., 2014)

Your Bibliography: Jetha, N., Semenchenko, V., Wishart, D., Cashman, N. and Marziali, A., 2014. Nanopore Analysis of Wild-Type and Mutant Prion Protein (PrPC): Single Molecule Discrimination and PrPC Kinetics. PLoS ONE, 8(2), p.e54982.

In-text: (Lacroux et al., 2014)

Your Bibliography: Lacroux, C., Comoy, E., Moudjou, M., Perret-Liaudet, A., Lugan, S., Litaise, C., Simmons, H., Jas-Duval, C., Lantier, I., Béringue, V., Groschup, M., Fichet, G., Costes, P., Streichenberger, N., Lantier, F., Deslys, J., Vilette, D. and Andréoletti, O., 2014. Preclinical Detection of Variant CJD and BSE Prions in Blood. PLoS Pathogens, 10(6), p.e1004202.

In-text: (Lambert and Amouyel, 2011)

Your Bibliography: Lambert, J. and Amouyel, P., 2011. Genetics of Alzheimer's disease: new evidences for an old hypothesis?. Current Opinion in Genetics & Development, 21(3), pp.295-301.

In-text: (Lambert et al., 2009)

Your Bibliography: Lambert, J., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M., Tavernier, B., Letenneur, L., Bettens, K., Berr, C., Pasquier, F., Fiévet, N., Barberger-Gateau, P., Engelborghs, S., De Deyn, P., Mateo, I., Franck, A., Helisalmi, S., Porcellini, E., Hanon, O., de Pancorbo, M., Lendon, C., Dufouil, C., Jaillard, C., Leveillard, T., Alvarez, V., Bosco, P., Mancuso, M., Panza, F., Nacmias, B., Bossù, P., Piccardi, P., Annoni, G., Seripa, D., Galimberti, D., Hannequin, D., Licastro, F., Soininen, H., Ritchie, K., Blanché, H., Dartigues, J., Tzourio, C., Gut, I., Van Broeckhoven, C., Alpérovitch, A., Lathrop, M. and Amouyel, P., 2009. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet, 41(10), pp.1094-1099.

In-text: (Levy and Becker, 2002)

Your Bibliography: Levy, Y. and Becker, O., 2002. Conformational polymorphism of wild-type and mutant prion proteins: Energy landscape analysis. Proteins: Structure, Function, and Genetics, 47(4), pp.458-468.

In-text: (Liberski and Surewicz, 2013)

Your Bibliography: Liberski, P. and Surewicz, W., 2013. Molecular Genetics of Gerstmann-Straussler-Scheinker Disease and Creutzfeld-Jakob Disease. Hereditary Genetics, 02(02).

In-text: (Liemann and Glockshuber, 1999)

Your Bibliography: Liemann, S. and Glockshuber, R., 1999. Influence of Amino Acid Substitutions Related to Inherited Human Prion Diseases on the Thermodynamic Stability of the Cellular Prion Protein. Biochemistry, 38(11), pp.3258-3267.

In-text: (Linden et al., 2008)

Your Bibliography: Linden, R., Martins, V., Prado, M., Cammarota, M., Izquierdo, I. and Brentani, R., 2008. Physiology of the Prion Protein. Physiological Reviews, 88(2), pp.673-728.

In-text: (Liu, Grundke-Iqbal, Iqbal and Gong, 2005)

Your Bibliography: Liu, F., Grundke-Iqbal, I., Iqbal, K. and Gong, C., 2005. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. European Journal of Neuroscience, 22(8), pp.1942-1950.

In-text: (Liu et al., 2005)

Your Bibliography: Liu, F., Igbal, K., Grundke-Igbal, I., Rossie, S. and Gong, C., 2005. Dephosphorylation of Tau by Protein Phosphatase 5: impairment in Alzheimer's disease. Journal of Biological Chemistry, 280(3), pp.1790-1796.

In-text: (Lugaresi et al., 1986)

Your Bibliography: Lugaresi, E., Medori, R., Montagna, P., Baruzzi, A., Cortelli, P., Lugaresi, A., Tinuper, P., Zucconi, M. and Gambetti, P., 1986. Fatal Familial Insomnia and Dysautonomia with Selective Degeneration of Thalamic Nuclei. New England Journal of Medicine, 315(16), pp.997-1003.

In-text: (Lukic et al., 2015)

Your Bibliography: Lukic, A., Uphill, J., Brown, C., Beck, J., Poulter, M., Campbell, T., Adamson, G., Hummerich, H., Whitfield, J., Ponto, C., Zerr, I., Lloyd, S., Collinge, J. and Mead, S., 2015. Rare structural genetic variation in human prion diseases. Neurobiology of Aging,.

In-text: (Masters et al., 1979)

Your Bibliography: Masters, C., Harris, J., Gajdusek, D., Gibbs, C., Bernoulli, C. and Asher, D., 1979. Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering. Annals of Neurology, 5(2), pp.177-188.

In-text: (Mawuenyega et al., 2010)

Your Bibliography: Mawuenyega, K., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J., Yarasheski, K. and Bateman, R., 2010. Decreased Clearance of CNS  -Amyloid in Alzheimer's Disease. Science, 330(6012), pp.1774-1774.

In-text: (Mead, 2003)

Your Bibliography: Mead, S., 2003. Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics. Science, 300(5619), pp.640-643.

In-text: (Mead, 2006)

Your Bibliography: Mead, S., 2006. Prion disease genetics. Eur J Hum Genet, 14(3), pp.273-281.

In-text: (Mead et al., 2001)

Your Bibliography: Mead, S., Mahal, S., Beck, J., Campbell, T., Farrall, M., Fisher, E. and Collinge, J., 2001. Sporadic—but Not Variant—Creutzfeldt-Jakob Disease Is Associated with Polymorphisms Upstream of PRNP Exon 1. The American Journal of Human Genetics, 69(6), pp.1225-1235.

In-text: (Messa et al., 2014)

Your Bibliography: Messa, M., Colombo, L., del Favero, E., Cantu, L., Stoilova, T., Cagnotto, A., Rossi, A., Morbin, M., Di Fede, G., Tagliavini, F. and Salmona, M., 2014. The Peculiar Role of the A2V Mutation in Amyloid-β (Aβ) 1-42 Molecular Assembly. Journal of Biological Chemistry, 289(35), pp.24143-24152.

In-text: (Moda et al., 2012)

Your Bibliography: Moda, F., Vimercati, C., Campagnani, I., Ruggerone, M., Giaccone, G., Morbin, M., Zentilin, L., Giacca, M., Zucca, I., Legname, G. and Tagliavini, F., 2012. Brain delivery of AAV9 expressing an anti-PrP monovalent antibody delays prion disease in mice. Prion, 6(4), pp.383-390.

In-text: (Murray et al., 2015)

Your Bibliography: Murray, M., Lowe, V., Graff-Radford, N., Liesinger, A., Cannon, A., Przybelski, S., Rawal, B., Parisi, J., Petersen, R., Kantarci, K., Ross, O., Duara, R., Knopman, D., Jack, C. and Dickson, D., 2015. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum. Brain,.

In-text: (Nelson et al., 2012)

Your Bibliography: Nelson, P., Alafuzoff, I., Bigio, E., Bouras, C., Braak, H., Cairns, N., Castellani, R., Crain, B., Davies, P., Tredici, K., Duyckaerts, C., Frosch, M., Haroutunian, V., Hof, P., Hulette, C., Hyman, B., Iwatsubo, T., Jellinger, K., Jicha, G., Kövari, E., Kukull, W., Leverenz, J., Love, S., Mackenzie, I., Mann, D., Masliah, E., McKee, A., Montine, T., Morris, J., Schneider, J., Sonnen, J., Thal, D., Trojanowski, J., Troncoso, J., Wisniewski, T., Woltjer, R. and Beach, T., 2012. Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status. Journal of Neuropathology & Experimental Neurology, 71(5), pp.362-381.

In-text: (Nishitsuji et al., 2009)

Your Bibliography: Nishitsuji, K., Tomiyama, T., Ishibashi, K., Ito, K., Teraoka, R., Lambert, M., Klein, W. and Mori, H., 2009. The E693Δ Mutation in Amyloid Precursor Protein Increases Intracellular Accumulation of Amyloid β Oligomers and Causes Endoplasmic Reticulum Stress-Induced Apoptosis in Cultured Cells. The American Journal of Pathology, 174(3), pp.957-969.

In-text: (Notari et al., 2014)

Your Bibliography: Notari, S., Xiao, X., Espinosa, J., Cohen, Y., Qing, L., Aguilar-Calvo, P., Kofskey, D., Cali, I., Cracco, L., Kong, Q., Torres, J., Zou, W. and Gambetti, P., 2014. Transmission Characteristics of Variably Protease-Sensitive Prionopathy. Emerg. Infect. Dis., 20(12), pp.2006-2014.

In-text: (Pan et al., 1993)

Your Bibliography: Pan, K., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. and Cohen, F., 1993. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences, 90(23), pp.10962-10966.

In-text: (Pauly and Harris, 1998)

Your Bibliography: Pauly, P. and Harris, D., 1998. Copper Stimulates Endocytosis of the Prion Protein. Journal of Biological Chemistry, 273(50), pp.33107-33110.

In-text: (Peden et al., 2014)

Your Bibliography: Peden, A., Sarode, D., Mulholland, C., Barria, M., Ritchie, D., Ironside, J. and Head, M., 2014. The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease. Acta Neuropathol Commun, 2(1), p.152.

In-text: (Peggion, Sorgato and Bertoli, 2014)

Your Bibliography: Peggion, C., Sorgato, M. and Bertoli, A., 2014. Prions and Prion-Like Pathogens in Neurodegenerative Disorders. Pathogens, 3(1), pp.149-163.

In-text: (Petersen et al., 1996)

Your Bibliography: Petersen, R., Parchi, P., Richardson, S., Urig, C. and Gambetti, P., 1996. Effect of the D178N Mutation and the Codon 129 Polymorphism on the Metabolism of the Prion Protein. Journal of Biological Chemistry, 271(21), pp.12661-12668.

In-text: (Poggiolini, Saverioni and Parchi, 2013)

Your Bibliography: Poggiolini, I., Saverioni, D. and Parchi, P., 2013. Prion Protein Misfolding, Strains, and Neurotoxicity: An Update from Studies on Mammalian Prions. International Journal of Cell Biology, 2013, pp.1-24.

In-text: (Poggiolini, Saverioni and Parchi, 2013)

Your Bibliography: Poggiolini, I., Saverioni, D. and Parchi, P., 2013. Prion Protein Misfolding, Strains, and Neurotoxicity: An Update from Studies on Mammalian Prions. International Journal of Cell Biology, 2013, pp.1-24.

In-text: (Pooler et al., 2013)

Your Bibliography: Pooler, A., Polydoro, M., Wegmann, S., Nicholls, S., Spires-Jones, T. and Hyman, B., 2013. Propagation of tau pathology in Alzheimer’s disease: identification of novel therapeutic targets. Alzheimer's Research & Therapy, 5(5), p.49.

In-text: (Prasansuklab and Tencomnao, 2013)

Your Bibliography: Prasansuklab, A. and Tencomnao, T., 2013. Amyloidosis in Alzheimer’s Disease: The Toxicity of Amyloid Beta (Aβ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy. Evidence-Based Complementary and Alternative Medicine, 2013, pp.1-10.

In-text: (Priola and McNally, 2009)

Your Bibliography: Priola, S. and McNally, K., 2009. The role of the prion protein membrane anchor in prion infection. Prion, 3(3), pp.134-138.

In-text: (Prusiner, 1998)

Your Bibliography: Prusiner, S., 1998. Prions. Proceedings of the National Academy of Sciences of the United States of America, 95(23), pp.13363–13383.

In-text: (Puoti et al., 2012)

Your Bibliography: Puoti, G., Bizzi, A., Forloni, G., Safar, J., Tagliavini, F. and Gambetti, P., 2012. Sporadic human prion diseases: molecular insights and diagnosis. The Lancet Neurology, 11(7), pp.618-628.

In-text: (Revett, Baker, Jhamandas and Kar, 2013)

Your Bibliography: Revett,, T., Baker, G., Jhamandas, J. and Kar, S., 2013. Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci, 38(1), pp.6-23.

In-text: (Riek et al., 1998)

Your Bibliography: Riek, R., Wider, G., Billeter, M., Hornemann, S., Glockshuber, R. and Wuthrich, K., 1998. Prion protein NMR structure and familial human spongiform encephalopathies. Proceedings of the National Academy of Sciences, 95(20), pp.11667-11672.

In-text: (Rodríguez-Martínez et al., 2012)

Your Bibliography: Rodríguez-Martínez, A., de Munain, A., Ferrer, I., Zarranz, J., Atarés, B., Villagra, N., Arteagoitia, J., Garrido, J. and Juste, R., 2012. Coexistence of protease sensitive and resistant prion protein in 129VV homozygous sporadic Creutzfeldt–Jakob disease: a case report. J Med Case Rep, 6(1), p.348.

In-text: (Rogers et al., 2006)

Your Bibliography: Rogers, J., Li, R., Mastroeni, D., Grover, A., Leonard, B., Ahern, G., Cao, P., Kolody, H., Vedders, L., Kolb, W. and Sabbagh, M., 2006. Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes. Neurobiology of Aging, 27(12), pp.1733-1739.

In-text: (Rupprecht et al., 2013)

Your Bibliography: Rupprecht, S., Grimm, A., Schultze, T., Zinke, J., Karvouniari, P., Axer, H., Witte, O. and Schwab, M., 2013. Does the Clinical Phenotype of Fatal Familial Insomnia Depend on PRNP codon 129 Methionine-Valine Polymorphism?. Journal of Clinical Sleep Medicine,.

In-text: (Salmon, 2013)

Your Bibliography: Salmon, R., 2013. How widespread is variant Creutzfeldt-Jakob disease?. BMJ, 347(oct15 5), pp.f5994-f5994.

In-text: (Sassi et al., 2014)

Your Bibliography: Sassi, C., Guerreiro, R., Gibbs, R., Ding, J., Lupton, M., Troakes, C., Al-Sarraj, S., Niblock, M., Gallo, J., Adnan, J., Killick, R., Brown, K., Medway, C., Lord, J., Turton, J., Bras, J., Morgan, K., Powell, J., Singleton, A. and Hardy, J., 2014. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease. Neurobiology of Aging, 35(12), pp.2881.e1-2881.e6.

In-text: (Schiff et al., 2008)

Your Bibliography: Schiff, E., Campana, V., Tivodar, S., Lebreton, S., Gousset, K. and Zurzolo, C., 2008. Coexpression of Wild-type and Mutant Prion Proteins Alters Their Cellular Localization and Partitioning into Detergent-resistant Membranes. Traffic, 9(7), pp.1101-1115.

In-text: (Schmitt-Ulms et al., 2009)

Your Bibliography: Schmitt-Ulms, G., Ehsani, S., Watts, J., Westaway, D. and Wille, H., 2009. Evolutionary Descent of Prion Genes from the ZIP Family of Metal Ion Transporters. PLoS ONE, 4(9), p.e7208.

In-text: (Senatore, Restelli and Chiesa, 2013)

Your Bibliography: Senatore, A., Restelli, E. and Chiesa, R., 2013. Synaptic Dysfunction in Prion Diseases: A Trafficking Problem?. International Journal of Cell Biology, 2013, pp.1-15.

In-text: (Shamsir and Dalby, 2007)

Your Bibliography: Shamsir, M. and Dalby, A., 2007. β-Sheet Containment by Flanking Prolines: Molecular Dynamic Simulations of the Inhibition of β-Sheet Elongation by Proline Residues in Human Prion Protein. Biophysical Journal, 92(6), pp.2080-2089.

In-text: (Shi et al., 2013)

Your Bibliography: Shi, Q., Xie, W., Zhang, B., Chen, L., Xu, Y., Wang, K., Ren, K., Zhang, X., Chen, C., Zhang, J. and Dong, X., 2013. Brain microglia were activated in sporadic CJD but almost unchanged in fatal familial insomnia and G114V genetic CJD. Virol J, 10(1), p.216.

In-text: (Shojaei et al., 2014)

Your Bibliography: Shojaei, F., Tavakolinia, N., Divsalar, A., Haertlé, T., Saboury, A., Nemat-Gorgani, M. and Abbracchio, M., 2014. Biochemical and immunological aspects of protein aggregation in neurodegenerative diseases. J IRAN CHEM SOC, 11(6), pp.1503-1512.

In-text: (Staderini et al., 2013)

Your Bibliography: Staderini, M., Aulić, S., Bartolini, M., Tran, H., González-Ruiz, V., Pérez, D., Cabezas, N., Martínez, A., Martín, M., Andrisano, V., Legname, G., Menéndez, J. and Bolognesi, M., 2013. A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer’s and Prion Diseases. ACS Medicinal Chemistry Letters, 4(2), pp.225-229.

In-text: (Stancu, Vasconcelos, Terwel and Dewachter, 2014)

Your Bibliography: Stancu, I., Vasconcelos, B., Terwel, D. and Dewachter, I., 2014. Models of β-amyloid induced Tau-pathology: the long and “folded” road to understand the mechanism. Molecular Neurodegeneration, 9(1), p.51.

In-text: (Tian et al., 2013)

Your Bibliography: Tian, H., Davidowitz, E., Lopez, P., Emadi, S., Moe, J. and Sierks, M., 2013. Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations. International Journal of Cell Biology, 2013, pp.1-9.

In-text: (Tian et al., 2013)

Your Bibliography: Tian, H., Davidowitz, E., Lopez, P., Emadi, S., Moe, J. and Sierks, M., 2013. Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations. International Journal of Cell Biology, 2013, pp.1-9.

In-text: (Ting et al., 2006)

Your Bibliography: Ting, J., Kelley, B., Lambert, T., Cook, D. and Sullivan, J., 2006. Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms. Proceedings of the National Academy of Sciences, 104(1), pp.353-358.

In-text: (Tong et al., 2004)

Your Bibliography: Tong, Y., Zhou, W., Fung, V., Christensen, M., Qing, H., Sun, X. and Song, W., 2004. Oxidative stress potentiates BACE1 gene expression and Aβ generation. Neurobiology of Aging, 25, p.S531.

In-text: (Valastyan and Lindquist, 2014)

Your Bibliography: Valastyan, J. and Lindquist, S., 2014. Mechanisms of protein-folding diseases at a glance. Disease Models & Mechanisms, 7(1), pp.9-14.

In-text: (van der Kamp and Daggett, 2009)

Your Bibliography: van der Kamp, M. and Daggett, V., 2009. The consequences of pathogenic mutations to the human prion protein. Protein Engineering Design and Selection, 22(8), pp.461-468.

In-text: (Vollmert et al., 2006)

Your Bibliography: Vollmert, C., Windl, O., Xiang, W., Rosenberger, A., Zerr, I., Wichmann, H., Bickeboller, H., Illig, T. and Kretzschmar, H., 2006. Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study. Journal of Medical Genetics, 43(10), pp.e53-e53.

In-text: (Wagner et al., 2013)

Your Bibliography: Wagner, J., Ryazanov, S., Leonov, A., Levin, J., Shi, S., Schmidt, F., Prix, C., Pan-Montojo, F., Bertsch, U., Mitteregger-Kretzschmar, G., Geissen, M., Eiden, M., Leidel, F., Hirschberger, T., Deeg, A., Krauth, J., Zinth, W., Tavan, P., Pilger, J., Zweckstetter, M., Frank, T., Bähr, M., Weishaupt, J., Uhr, M., Urlaub, H., Teichmann, U., Samwer, M., Bötzel, K., Groschup, M., Kretzschmar, H., Griesinger, C. and Giese, A., 2013. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease. Acta Neuropathologica, 125(6), pp.795-813.

In-text: (Will, 2003)

Your Bibliography: Will, R., 2003. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. British Medical Bulletin, 66(1), pp.255-265.

In-text: (Wille et al., 2009)

Your Bibliography: Wille, H., Bian, W., McDonald, M., Kendall, A., Colby, D., Bloch, L., Ollesch, J., Borovinskiy, A., Cohen, F., Prusiner, S. and Stubbs, G., 2009. Natural and synthetic prion structure from X-ray fiber diffraction. Proceedings of the National Academy of Sciences, 106(40), pp.16990-16995.

In-text: (Xiao, 2014)

Your Bibliography: Xiao, X., 2014. Comparative Study of Prions in Iatrogenic and Sporadic Creutzfeldt-Jakob Disease. Journal of Clinical & Cellular Immunology, 05(04).

In-text: (Xu, Kurup, Nairn and Lombroso, 2012)

Your Bibliography: Xu, J., Kurup, P., Nairn, A. and Lombroso, P., 2012. Striatal-Enriched Protein Tyrosine Phosphatase in Alzheimer’s Disease. Current State of Alzheimer's Disease Research and Therapeutics, pp.303-325.

In-text: (Zahn et al., 2000)

Your Bibliography: Zahn, R., Liu, A., Luhrs, T., Riek, R., von Schroetter, C., Lopez Garcia, F., Billeter, M., Calzolai, L., Wider, G. and Wuthrich, K., 2000. NMR solution structure of the human prion protein. Proceedings of the National Academy of Sciences, 97(1), pp.145-150.

In-text: (Zhang et al., 2000)

Your Bibliography: Zhang, Y., Swietnicki, W., Zagorski, M., Surewicz, W. and Sonnichsen, F., 2000. Solution Structure of the E200K Variant of Human Prion Protein: Implications For The Mechanism Of Pathogenesis In Familial Prion Diseases. Journal of Biological Chemistry, 275(43), pp.33650-33654.

In-text: (Zheng et al., 2002)

Your Bibliography: Zheng, W., Bastianetto, S., Mennicken, F., Ma, W. and Kar, S., 2002. Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience, 115(1), pp.201-211.

In-text: (Zou et al., 2013)

Your Bibliography: Zou, W., Gambetti, P., Xiao, X., Yuan, J., Langeveld, J. and Pirisinu, L., 2013. Prions in Variably Protease-Sensitive Prionopathy: An Update. Pathogens, 2(3), pp.457-471.

In-text: (Zou et al., 2010)

Your Bibliography: Zou, W., Puoti, G., Xiao, X., Yuan, J., Qing, L., Cali, I., Shimoji, M., Langeveld, J., Castellani, R., Notari, S., Crain, B., Schmidt, R., Geschwind, M., DeArmond, S., Cairns, N., Dickson, D., Honig, L., Torres, J., Mastrianni, J., Capellari, S., Giaccone, G., Belay, E., Schonberger, L., Cohen, M., Perry, G., Kong, Q., Parchi, P., Tagliavini, F. and Gambetti, P., 2010. Variably protease-sensitive prionopathy: A new sporadic disease of the prion protein. Annals of Neurology, 68(2), pp.162-172.

In-text: (Zuo et al., 2006)

Your Bibliography: Zuo, L., van Dyck, C., Luo, X., Kranzler, H., Yang, B. and Gelernter, J., 2006. Variation at APOE and STH loci and Alzheimer's disease. Behavioral and Brain Functions, 2(1), p.13.